Note that changes to the agenda may occur. Any changes will be reflected here. Stay up to date by revisiting this page.
08:30 Registration, partnering sessions and networking
09:15 Welcome and introduction
Korbinian Löbmann, Chief Scientific Officer and Co-founder, Zerion Pharma
09:20 Delivery of drugs in the oral cavity – Opportunities of a new patch technology
Mai Bay Stie, Postdoc, Department of Pharmacy, University of Copenhagen
09:50 PharmaShell – The high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision
Oliver Hedge, Senior Formulation Scientist, Nanexa
10:20 Targeting bacterial biofilms with in situ hydrogels
Line Hagner Nielsen, Associate Professor, DTU Health Tech, Technical University of Denmark
10:50 Coffee, partnering sessions and networking
11:30 Nasal powder vaccines enabled by the AmorphOX® drug delivery technology – An opportunity for thermostable, needle-free vaccines
Robert Rönn, SVP and Head of R&D, Orexo
12:00 From paper to practice: The role of supersaturation in real-world oral formulations
Ian Degeling, CTO and Co-founder, SeraNovo
12:30 Lunch, partnering sessions and networking
13:20 Order and disorder in pharmaceutical solids – and what they mean for drug delivery
Thomas Rades, Research Chair in Pharmaceutical Design and Drug Delivery, University of Copenhagen
13:50 Investigation of polyAmorphism – The peculiar cases of hydrochlorothiazide and indomethacin
Inês C. B. Martins, Associate Professor, Department of Pharmacy, University of Copenhagen
14:20 Critical success factors in early development of biologics
Sara Malekkhaiat Häffner, Formulation Scientist, RISE Research Institutes of Sweden
Jenny Blomqvist, Senior Analytical Scientist, RISE Research Institutes of Sweden
14:50 Summary and conclusion
Approx. 14:55 End of agenda